Yamanouchi Pharmaceutical Co., Ltd. And Fujisawa Pharmaceutical Co., Ltd. Unite To Form Astellas Pharma Inc., North American Headquarters To Be In Chicago
10/19/2005 5:13:11 PM
More...
|
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval
10/19/2005 5:13:03 PM
More...
|
Gloucester Pharmaceuticals, Inc. Initiates Pivotal Trial With FK228 In Cutaneous T-Cell Lymphoma; FDA Approves Trial Protocol Under Special Protocol Assessment
10/19/2005 5:12:52 PM
More...
|
Cardiome Pharma Corp.'s (COM.TO) Pivotal AF Study Achieves Primary Endpoint
10/19/2005 5:12:30 PM
More...
|
Phase Forward Partners With Fujitsu To Promote InForm EDC Solution In Japan
10/19/2005 5:11:42 PM
More...
|
Fujisawa Pharmaceutical Co., Ltd. And Yamanouchi Pharmaceutical Co., Ltd. Will Establish Zepharma Inc., An OTC Pharmaceutical Company
10/19/2005 5:11:27 PM
More...
|
Evotec OAI (Germany) (DX:EVT) Enters Into Integrated Virtual Screening And Medicinal Chemistry Agreement With Fujisawa Pharmaceutical Co., Ltd.
10/19/2005 5:10:52 PM
More...
|
American Pharmaceutical Partners (APPX) Receives Approval For Adenosine
10/19/2005 5:10:45 PM
More...
|
Atrix Laboratories, Inc. (ATRX) And Fujisawa Healthcare Submit New Drug Application For Acne Product
10/19/2005 5:10:29 PM
More...
|
Hemispherx Biopharma (HEB) Signs Option Agreement For Ampligen With Fujisawa Pharmaceutical Co., Ltd.
10/19/2005 5:10:02 PM
More...
|
|